Dmitry Bivol dominated Michael Eifert on Saturday at the UMMC Arena in Ekaterinburg, Russia to retain his unified light ...
Free Malaysia Today on MSN
From K-pop to K-glow, lasers, facial firming drive South Korea’s new tourism wave
Demand for non-invasive skin treatments is outpacing cosmetic surgery, while growth in foreign patients is surpassing that of ...
Important progress across four clinical-stage programs demonstrating depth and breadth of obesity pipeline Initiated five late-stage global clinical trials in obesity, including the ribupatide ...
Important progress across four clinical-stage programs demonstrating depth and breadth of obesity pipeline Initiated five late-stage global clinical trials in obesity, including the ribupatide injecti ...
CarBuzz on MSN
The Last Manual M5 Isn't The One You're Thinking Of
And How Cadillac Capitalized On BMW's Shift To Automatics ...
Analysts are heralding bepirovirsen as a potentially strong future growth driver for GSK and its infectious disease portfolio.
From the track-ready R1 to the rugged TW200, these Yamaha motorcycles are built to last with proven engines and durable ...
Britain’s 2026 heatwave is no longer just about melting train platforms, sleepless nights, and desperate supermarket fan ...
Morning Overview on MSN
A new two-pill combo just slashed LDL cholesterol by 48.6% in a phase 3 trial — the sharpest drop ever logged without adding a statin to the mix
For the roughly 30 million American adults who have been told their cholesterol is too high but cannot stomach a statin, the treatment menu has been frustratingly short: a modest pill called ezetimibe ...
Crude rises after US strikes on Iran dampen hopes of peace deal, with experts saying talks appear stuck in ‘endless loop’ ...
Lupron Depot is a brand-name intramuscular injection (an injection given into the muscle). It’s prescribed for advanced prostate cancer and other hormone-related conditions, such as endometriosis, ...
TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in adults with relapsing forms of multiple sclerosis (RMS) at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results